Psychopharmacology

Paper Summary:

This paper describes the pharmaceuticals developed to treat severe depression. The focus of the paper is on drugs used to treat people with atypical mental illnesses and, in particular, atypical forms of depression. Topics such as how these drugs work, their side effects, and the importance of educating the patient about the drugs are all covered by the paper.

From the Paper:

"Monoamine Oxidase Inhibitors or MAOs were the first pharmaceuticals developed. Although they have more side effects than the tricyclic and latest selective serotonin reuptake inhibitors (SSRIs), they are found to be very helpful particularly in "atypical" and treatment-resistant situations. They can "produce dramatic improvements in some forms of depression" (Gorman, 1990, p. 83). The generic and brand names of the three marketed in the United States are bedisocarboxazid (Marplan), phenelzine sulfate (Nardil) and tranylcypromine sulfate (Parnate)."

More papers on Psychopharmacology:

• Term Paper # 128937 : "Psychopharmacology"
• Essay # 8515 : "Psychopharmacology"
• Essay # 29322 : "Psychopharmacology"

APA Citation:

MLA Citation: